# Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.

> **NCT02100046** · PHASE2 · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 114 (actual)

## Conditions studied

- Neuropathic Traumatic Pain
- Pain NRS ≥ 4
- Peripheral Neuropathic Pain
- Neuropathic Pain Diagnostic Questionnaire (DN4) ≥ 4

## Interventions

- **DRUG:** Zarontin® (ethosuximide) and Stodal®

## Key facts

- **NCT ID:** NCT02100046
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-09
- **Final completion:** 2017-01-01
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02100046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02100046, "Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02100046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*